XML 34 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
Redeemable Convertible Preferred Stock Series B [Member]
Series B redeemable convertible preferred stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balances at Dec. 31, 2013 $ 707,000 $ 36,000 $ 362,454,000 $ (385,115,000) $ (22,625,000)
Balances (in shares) at Dec. 31, 2013 8,859,978 3,650,711      
Net income (loss)       23,109,000 23,109,000
Accretion of dividends on Series B redeemable convertible preferred stock $ 1,285,000   (1,285,000)   (1,285,000)
Warrants exercised   $ 1,000 1,594,000   1,595,000
Warrants exercised (in shares)   54,683      
Conversion of Series B redeemable convertible preferred stock to common stock, value $ (2,000) $ 1,000 706,000   707,000
Conversion of Series B redeemable convertible preferred stock to common stock, shares (188,938) 37,788      
Stock-based compensation     775,000   775,000
Stock-based compensation - severance     1,161,000   1,161,000
Shares released from escrow   $ 2,000 (2,000)    
Shares released from escrow (in shares)   240,000      
Balances at Dec. 31, 2014 $ 1,990,000 $ 40,000 365,403,000 (362,006,000) 3,437,000
Balances (in shares) at Dec. 31, 2014 8,671,040 3,983,182      
Net income (loss)       (516,000) (516,000)
Accretion of dividends on Series B redeemable convertible preferred stock $ 1,307,000   (1,307,000)   (1,307,000)
Amount reclassified to Series B redeemable convertible stock to accrete to its redemption value 8,971,000   (8,971,000)   (8,971,000)
Warrants exercised   $ 1,000 1,072,000   1,073,000
Warrants exercised (in shares)   56,645      
Conversion of Series B redeemable convertible preferred stock to common stock, value $ (378,000) $ 2,000 1,504,000   1,506,000
Conversion of Series B redeemable convertible preferred stock to common stock, shares (1,143,187) 228,637      
Common stock issued in March 2015 financing, net of offering costs   $ 16,000 8,250,000   8,266,000
Common stock issued in March 2015 financing, net of offering costs (in shares)   1,575,758      
Warrants reclassified from liabilities to equity due to amendment of warrants     5,462,000   5,462,000
Warrants reclassified from liabilities to equity due to increase in authorized shares     3,281,000   $ 3,281,000
Exercise of common stock options (shares)   39,281     214,815
Stock-based compensation     479,000   $ 479,000
Stock-based compensation - severance     4,000   4,000
Balances at Dec. 31, 2015 $ 11,890,000 $ 59,000 $ 375,177,000 $ (362,522,000) $ 12,714,000
Balances (in shares) at Dec. 31, 2015 7,527,853 5,883,503